Trials / Conditions / RET-altered Solid Tumors
RET-altered Solid Tumors
3 registered clinical trials studyying RET-altered Solid Tumors — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study of APS03118 in Advanced Solid Tumors Harboring RET Mutations or Fusions NCT05653869 | Applied Pharmaceutical Science, Inc. | Phase 1 |
| Recruiting | Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities NCT04683250 | Taiho Pharmaceutical Co., Ltd. | Phase 1 / Phase 2 |
| Completed | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Can NCT03037385 | Hoffmann-La Roche | Phase 1 / Phase 2 |